Table 3

Summary statistics for outcomes in ECLIPSE and ERICA cohorts*

OutcomeECLIPSEERICA
Male (N=1296)Male (N=386)Female (N=244)
No of subjectsNo of events†No of subjectsNo of events†No of subjectsNo of events†
≥1 H-AECOPD1296412 (32%)386153 (40%)244106 (43%)
Cardiovascular-related hospitalisation or death386138 (36%)24478 (32%)
Respiratory-related mortality38644 (11%)24428 (11%)
All-cause mortality1296112 (9%)38685 (22%)24443 (18%)
Exacerbation rate
(H-AECOPD events per year)
1530.45 (0.23, 0.86)1060.25 (0.21, 0.60)
LOS (days)1532 (1, 4)1063 (1, 7)
  • *Statistics summarised using median (IQR) for continuous variables and n (%) for categorical variables.

  • †Unless otherwise stated.

  • ECLIPSE, Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points; ERICA, Evaluation of the Role of Inflammation in Chronic Airways; H-AECOPD, acute exacerbation of chronic obstructive pulmonary disorder; LOS, length of stay.